Works matching IS 17588340 AND DT 2014 AND VI 6 AND IP 5
Results: 5
Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 210, doi. 10.1177/1758834014535650
- By:
- Publication type:
- Article
Novel agents in development for advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 240, doi. 10.1177/1758834014532510
- By:
- Publication type:
- Article
Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 222, doi. 10.1177/1758834014544892
- By:
- Publication type:
- Article
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 229, doi. 10.1177/1758834014544121
- By:
- Publication type:
- Article
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 202, doi. 10.1177/1758834014539183
- By:
- Publication type:
- Article